HUP0402471A2 - Vakcina - Google Patents

Vakcina

Info

Publication number
HUP0402471A2
HUP0402471A2 HU0402471A HUP0402471A HUP0402471A2 HU P0402471 A2 HUP0402471 A2 HU P0402471A2 HU 0402471 A HU0402471 A HU 0402471A HU P0402471 A HUP0402471 A HU P0402471A HU P0402471 A2 HUP0402471 A2 HU P0402471A2
Authority
HU
Hungary
Prior art keywords
vaccine
subject
conjugate vaccine
streptococcus pneumonia
optimal formulation
Prior art date
Application number
HU0402471A
Other languages
English (en)
Inventor
Craig Anthony Joseph Laferriere
Jan Poolman
Original Assignee
Glaxosmithkline Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biologicals S.A. filed Critical Glaxosmithkline Biologicals S.A.
Publication of HUP0402471A2 publication Critical patent/HUP0402471A2/hu
Publication of HUP0402471A3 publication Critical patent/HUP0402471A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP

Abstract

A találmány tárgya több szerotípusú Streptococcus pneumoniakonjugátum-vakcina optimális kiszerelése. Ó
HU0402471A 2001-12-18 2002-12-18 Vaccine HUP0402471A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0130215.7A GB0130215D0 (en) 2001-12-18 2001-12-18 Vaccine
PCT/EP2002/014476 WO2003051392A2 (en) 2001-12-18 2002-12-18 Streptococcus pneumoniae vaccine

Publications (2)

Publication Number Publication Date
HUP0402471A2 true HUP0402471A2 (hu) 2005-03-29
HUP0402471A3 HUP0402471A3 (en) 2005-04-28

Family

ID=9927830

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0402471A HUP0402471A3 (en) 2001-12-18 2002-12-18 Vaccine

Country Status (19)

Country Link
US (1) US20050214329A1 (hu)
EP (1) EP1463519A2 (hu)
JP (1) JP2005516932A (hu)
KR (1) KR20040074091A (hu)
CN (1) CN1635904A (hu)
AU (1) AU2002361007A1 (hu)
BR (1) BR0215089A (hu)
CA (1) CA2470645A1 (hu)
CO (1) CO5590937A2 (hu)
GB (1) GB0130215D0 (hu)
HU (1) HUP0402471A3 (hu)
IL (1) IL162383A0 (hu)
IS (1) IS7297A (hu)
MX (1) MXPA04006073A (hu)
NO (1) NO20043018L (hu)
PL (1) PL370804A1 (hu)
RU (1) RU2004117775A (hu)
WO (1) WO2003051392A2 (hu)
ZA (1) ZA200404803B (hu)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763244B1 (fr) 1997-05-14 2003-08-01 Pasteur Merieux Serums Vacc Composition vaccinale multivalente a porteur mixte
US20070184072A1 (en) 2005-04-08 2007-08-09 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
KR20150061019A (ko) * 2005-04-08 2015-06-03 와이어쓰 엘엘씨 다가 폐렴구균 다당류-단백질 접합체 조성물
AU2011253684B8 (en) * 2005-04-08 2013-07-11 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US7955605B2 (en) 2005-04-08 2011-06-07 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
AR058707A1 (es) * 2005-12-22 2008-02-20 Glaxosmithkline Biolog Sa Vacuna, procedimiento para fabricarla y su uso
AU2012216698B2 (en) * 2005-12-22 2014-03-06 Glaxosmithkline Biologicals Sa Pneumococcal polysaccharide conjugate vaccine
US20070253985A1 (en) * 2006-04-26 2007-11-01 Wyeth Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations
US8808707B1 (en) 2006-05-08 2014-08-19 Wyeth Llc Pneumococcal dosing regimen
CA2661210A1 (en) * 2006-08-17 2008-02-21 The Uab Research Foundation Diagnosing pneumococcal pneumonia
CN1971275B (zh) * 2006-12-06 2012-07-04 云南沃森生物技术股份有限公司 肺炎链球菌6b型、18c型、19f型、23f型多糖结合物中游离多糖含量的测定方法
CA2685506A1 (en) * 2007-05-02 2008-11-13 Glaxosmithkline Biologicals S.A. Vaccine
EA200901578A1 (ru) * 2007-06-26 2010-08-30 Глаксосмитклайн Байолоджикалс С.А. Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae
US20160228500A9 (en) * 2007-07-23 2016-08-11 Martina Ochs Immunogenic Polypeptides and Monoclonal Antibodies
BRPI0814127A2 (pt) * 2007-07-23 2015-02-03 Sanofi Pasteur Ltd Polipeptídeos imunegênicos e anticorpos monoclonais
GB201003924D0 (en) * 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
US9944680B2 (en) 2010-12-03 2018-04-17 Sandfi Pasteur Limited Composition for immunization against Streptococcus pneumoniae
RU2634405C2 (ru) * 2012-01-30 2017-10-26 Серум Инститьют Оф Индия Лтд. Иммуногенная композиция
US20140105927A1 (en) * 2012-10-17 2014-04-17 Glaxosmithkline Biologicals S.A. Immunogenic composition
CN104853768B (zh) * 2012-10-17 2019-04-19 葛兰素史密丝克莱恩生物有限公司 免疫原性组合物
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
CN106109486A (zh) * 2015-07-06 2016-11-16 北京科兴中维生物技术有限公司 一种组合物及其制备方法与应用
WO2018144799A1 (en) 2017-02-03 2018-08-09 SCHADECK, Eva, Barbara Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
WO2018227177A1 (en) 2017-06-10 2018-12-13 Inventprise, Llc Multivalent conjugate vaccines with bivalent or multivalent conjugate polysaccharides that provide improved immunogenicity and avidity
KR102486891B1 (ko) 2018-02-05 2023-01-10 사노피 파스퇴르 인코포레이티드 다가 폐렴구균성 다당류-단백질 접합체 조성물
CA3096358A1 (en) * 2018-04-18 2019-10-24 Sk Bioscience Co., Ltd. Streptococcus pneumoniae capsular polysaccharide and immunogenic conjugate thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811102A (en) * 1995-06-07 1998-09-22 National Research Council Of Canada Modified meningococcal polysaccharide conjugate vaccines
FR2763244B1 (fr) * 1997-05-14 2003-08-01 Pasteur Merieux Serums Vacc Composition vaccinale multivalente a porteur mixte
PL203917B1 (pl) * 1999-03-19 2009-11-30 Glaxosmithkline Biolog Sa Kompozycja immunogenna, sposób jej wytwarzania oraz zastosowanie

Also Published As

Publication number Publication date
US20050214329A1 (en) 2005-09-29
WO2003051392A3 (en) 2003-11-13
EP1463519A2 (en) 2004-10-06
KR20040074091A (ko) 2004-08-21
RU2004117775A (ru) 2005-04-20
PL370804A1 (en) 2005-05-30
MXPA04006073A (es) 2005-03-31
ZA200404803B (en) 2005-08-29
CA2470645A1 (en) 2003-06-26
BR0215089A (pt) 2004-11-16
JP2005516932A (ja) 2005-06-09
CN1635904A (zh) 2005-07-06
AU2002361007A1 (en) 2003-06-30
IS7297A (is) 2004-06-03
CO5590937A2 (es) 2005-12-30
HUP0402471A3 (en) 2005-04-28
NO20043018L (no) 2004-07-15
WO2003051392A2 (en) 2003-06-26
IL162383A0 (en) 2005-11-20
GB0130215D0 (en) 2002-02-06

Similar Documents

Publication Publication Date Title
HUP0402471A2 (hu) Vakcina
HUP0303996A2 (hu) Vakcinakészítmények
IS7133A (is) Afleiða beta-amyloid - T-frumu-mótefnavísisbóluefni
HUP0200367A2 (en) Streptococcus vaccine
DE60231151D1 (de) Silizium-mikrofon
CY1105586T1 (el) Ιμιδαζοκουινολινες υποκατεστημενες με θειοαιθερα
DK1198233T3 (da) Sulfonamid- og sulfamidsubstituerede imidazoquinoliner
TR200103574T2 (tr) Amid ikameli/katkılı imidazokinolinler
HUP0400149A2 (hu) Új fertőtlenítőszerek
BR0306905A (pt) Vacinas de flavivìrus
DK1427444T3 (da) West-nil-vaccine
DK1292304T3 (da) Zolpidem Hemitartrat
HUP0302636A2 (hu) Hasított burkolt víruskészítmény
NO20033882D0 (no) Vaksine
NO20033737D0 (no) PEG-konjugater av IIGT-NK4
ITMI20021822A1 (it) Manicotto elastico e procedimento per la fabbricazione di un manicotto elastico
ITTO20020789A1 (it) Formulazione solida
HUP0302738A2 (hu) SARP-1 alkalmazása scleroderma kezelésére és megelőzésére
NO20040966L (no) Orale vaksiner.
FR2833982B1 (fr) Plaque de platre
DE50212676D1 (de) Exopolysaccharidproduktion
GB2370770B (en) Uses of Streptococcus Vaccines
NO20025765D0 (no) Kombinasjonssett for behandling av malaria
CY1110139T1 (el) Γλυκοπεπτιδικα αντιβιοτικα
ATE478155T1 (de) Glycopeptidantibiotika

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished